Vervaunt is an energetic and forward-thinking eCommerce and paid media consultancy, born out of a mutual passion for helping premium brands and ambitious retailers grow online, sustainably.
We help boost sales for your Shopify store, helping wellness & lifestyle brands grow with Shopify through strategy, design, and development that delivers results.
Jacksonville, United StatesMarketing & Advertising
SparkLayer is the powerful platform that transforms your existing website into a fully featured B2B solution. Rapid to setup, simple to use, and integrates beautifully with your existing systems.
AstraZeneca is a global pharmaceutical company focused on the research, development, and commercialization of prescription medicines. With around 90,000 employees in 85 countries, the company aims to harness scientific advancements for the benefit of people and society. AstraZeneca operates in various functions, including Clinical Development, Regulatory Affairs, Finance, IT, and Manufacturing.
The company specializes in three main therapeutic areas: oncology, respiratory, and immunology. In oncology, AstraZeneca is dedicated to developing innovative treatments that aim to redefine cancer care. In the respiratory and immunology sectors, the company works to improve outcomes for patients with asthma and COPD, as well as other immune-driven diseases. Additionally, AstraZeneca has expanded its focus on rare diseases through its acquisition of Alexion, enhancing its capabilities in this area. The company is committed to advancing science and creating impactful therapies across multiple health conditions.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, includingmore
